Target intelligence / Profile preview

novel transcript, antisense to NR3C1 (ENSG00000305502)

Molecular classification: long noncoding RNA (lncRNA), antisense RNA

Overview

ENSG00000305502 ("novel transcript, antisense to NR3C1") is an uncharacterized computationally predicted RNA, located antisense to the NR3C1 gene locus which encodes the glucocorticoid receptor. There is currently no evidence that this transcript encodes a functional molecule or acts as a therapeutic target. Structured biomedical databases and literature do not report biological function, disease association, or drug interaction for this entity. By contrast, the NR3C1 gene encodes the canonical glucocorticoid receptor and is a well-established receptor, transcription factor, and drug target for glucocorticoids in immune, inflammatory, and stress-related disorders.

Other names: antisense NR3C1 transcript

Beyond the preview

Go deeper on novel transcript, antisense to NR3C1 (ENSG00000305502).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on novel transcript, antisense to NR3C1 (ENSG00000305502).

Explore the full profile